Compare LIC MF Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹200 | ₹100 |
Expense Ratio | 2.45 | 1.87 |
NAV | ₹28.87 | ₹39.64 |
Fund Started | 08 Feb 2019 | 25 Jun 2018 |
Fund Size | ₹86.00 Cr | ₹6459.82 Cr |
Exit Load | Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹200
₹100
Expense Ratio
2.45
1.87
NAV
₹28.87
₹39.64
Fund Started
08 Feb 2019
25 Jun 2018
Fund Size
₹86.00 Cr
₹6459.82 Cr
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Exit load of 1% if redeemed within 15 days.
1 Year | -3.33% | 3.14% |
3 Year | 19.75% | 27.34% |
5 Year | 11.89% | 17.86% |
1 Year
-3.33%
3.14%
3 Year
19.75%
27.34%
5 Year
11.89%
17.86%
Equity | 98.46% | 97.70% |
Cash | 1.54% | 2.30% |
Equity
98.46%
97.70%
Cash
1.54%
2.30%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.47% |
Apollo Hospitals Enterprise Ltd. | 5.73% |
Torrent Pharmaceuticals Ltd. | 5.68% |
Cipla Ltd. | 5.56% |
Neuland Laboratories Ltd. | 4.85% |
Divi's Laboratories Ltd. | 4.64% |
Fortis Healthcare Ltd. | 4.50% |
Aurobindo Pharma Ltd. | 4.46% |
Piramal Pharma Ltd. | 4.32% |
Alkem Laboratories Ltd. | 3.41% |
Sun Pharmaceutical Industries Ltd. | 12.83% |
Dr. Reddy's Laboratories Ltd. | 9.81% |
Cipla Ltd. | 8.00% |
Divi's Laboratories Ltd. | 7.48% |
Aurobindo Pharma Ltd. | 6.04% |
Lupin Ltd. | 5.70% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 2.97% |
Cohance Lifesciences Ltd. | 2.68% |
Name | Karan Doshi | Dharmesh Kakkad |
Start Date | 31 Oct 2025 | 23 Feb 2021 |
Name
Karan Doshi
Dharmesh Kakkad
Start Date
31 Oct 2025
23 Feb 2021
Description | The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 08 Feb 2019 | 25 Jun 2018 |
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
08 Feb 2019
25 Jun 2018